Patrick Burton - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Patrick Burton's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Patrick Burton

Patrick Burton

Verified

Editor, PharmaBoardroom

Madrid

Beats

Primary beats

Final Covers

News and community

Doesn’t Cover

Partisan politics, generic hot takes, art, fashion

Journalist Type

-

Seniority Positions

-

Medium Formats

-

Content

Total articles 323

  • Rare Diseases in Saudi Arabia: Challenges & Opportunities

    By Patrick Burton| PharmaBoardroom@ Rare diseases, by definition, only affect small patient populations. However, when the more than 7,000 known rare conditions are taken together, their impact on health, societies, and economies is enormous. Moreover, over 90 percent of rare diseases have no known treatment, and rare disease patients often face delayed diagnoses and a lack of specialised care compared to those suffering from more common and well-funded conditions.

    By Patrick Burton · PharmaBoardroom

    Apr. 01, 2025

  • MEA: Egypt’s Latest Biomanufacturing Push; Hikma Targets Obesity; HIV and TB Resurgence

    By Patrick Burton| PharmaBoardroom@ The latest pharma and healthcare news from the dynamic Middle East and Africa market, which reached USD 32.6 billion in value last year according to IQVIA. With supply security of essential medicines and vaccines still a hot-button issue, Egypt and Morocco are establishing a regional biomanufacturing hub for North Africa. Elsewhere, Hikma is attempting to jump aboard the runaway GLP-1 obesity drug train by launching its own generic versions of blockbuster products.

    By Patrick Burton · PharmaBoardroom

    Mar. 17, 2025

  • Rare Diseases in Saudi Arabia: Challenges & Opportunities

    By Patrick Burton| PharmaBoardroom@ Rare diseases, by definition, only affect small patient populations. However, when the more than 7,000 known rare conditions are taken together, their impact on health, societies, and economies is enormous. Moreover, over 90 percent of rare diseases have no known treatment, and rare disease patients often face delayed diagnoses and a lack of specialised care compared to those suffering from more common and well-funded conditions.

    By Patrick Burton · PharmaBoardroom

    Apr. 01, 2025

As seen in

Company Info

PharmaBoardroom

PharmaBoardroom is a global platform that connects C-level executives in the healthcare and life sciences industries. It serves as a valuable resource for senior professionals, including consultants, regulators, and vendors, by providing insights into local and global markets. The platform offers a variety of services, including exclusive interviews with industry leaders, comprehensive market overviews, and daily updates on the latest news in the sector. Additionally, PharmaBoardroom maintains a database of important companies and business leaders, which aids in networking and business strategy development. Incorporated in the United Kingdom in 2018, PharmaBoardroom is classified under publishing activities. It plays a significant role in facilitating informed decision-making by sharing experiences and best practices among industry leaders.

England, United Kingdom

+44 17 0782 8754

Founded: 2012